Introduction
Pulmonary arterial hypertension (PAH) is a severely devastating disease characterized by progressive concentric remodelling of small pulmonary arteries resulting in increasing pulmonary vascular resistance (PVR) and right-sided heart failure and eventually death. 1, 2 Besides the well-known usual symptoms of PAH such as dyspnea, exercise intolerance, cyanosis, palpitations, syncope, and refractory edema, chest pain sometimes indistinguishable from classic angina pectoris has also been reported to occur in 7-29% of patients. pulmonary artery (PA) main trunk may cause angina in PAH. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] This causal relationship between PA enlargement and proximal LMCA compression (Co) in certain circumstances has been increasingly reported. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] PA aneurysm (A) has been documented in post-mortem examinations very rarely, and has been documented to occur in younger age group than those in aortic aneurysms with an equal sex incidence. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Eighty-nine per cent of all PAAs have been reported to be located in the main PA, and its extension to left PA is more common than to right PA. [18] [19] [20] More than half of all PAAs have been documented in patients with PAH associated with congenital heart disease (APAH-CHD). [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Cystic medial necrosis due to structural changes in elastin and collagen under the increased PA pressure or turbulent flow through the stenotic or abnormally opening pulmonary valve or shear stress resulting from left to right shunt flow are proposed mechanisms of transformation to PAAs. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] However, the incidence of LMCA-Co in PAH or other clinical forms of pulmonary hypertension (PH) remains to be established, and risk-based screening algorithms and optimal management strategies for both PAAs and LMCA-Co in these settings need to be determined. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] In this single-centre prospective study, we aimed to evaluate incidence, clinical, and haemodynamic correlates and management strategies of LMCA-Co in patients with PAH.
Methods
Our study group comprised of 269 patients (female 166, age 52.9 ± 17.3 years) out of overall 498 patients with confirmed PH (54%) who were enrolled into the single-centre, prospective and observational EvalUation of Pulmonary Hypertension Risk factors AssociaTEd with Survival (EUPHRATES) study, and underwent coronary angiography (CA) because of the PAA on echocardiography, angina or incidentally detected LMCA-Co on diagnostic evaluation with multidetector computed tomography (MDCT).
The diagnostic algorithms, clinical and haemodynamic definitions and management strategies have been based on ESC/ERS 2009 PH Guidelines, and have also been revised after publication of the ESC/ERS 2015 PH Guidelines.
1,2 Functional class (FC) assessment, six-minute walk distance (6MWD) and Doppler echocardiography have been routinely performed at the periodic assessments whereas repeat right heart catheterization has been performed in case of clinical worsening episodes due to PH. We defined the PAA as presence of PA diameter >30 mm on echocardiography and/or MDCT. Only femoral venous route with a 6-Fr sheath was used for right heart catheterization, and 6-Fr sheath was also used for femoral arterial access for left heart catheterization and/or CA procedures. The optimal planes to visualize the external compression and narrowing of proximal LMCA have been investigated, and the LMCA-Co was defined as the presence of diameter stenosis > _ 50% in reference distal LMCA segment on two consecutive angiographic planes, and the take-off angle of proximal LMCA segment in reference to left sinus of Valsalva was also evaluated. The LMCA-Co and need for stenting were initially assessed from recorded CA images by two experienced interventional cardiologists who are blinded for clinical status separately, and a final consensus for optimal management strategy was achieved in all patients.
The study protocol was approved by Institutional Ethics Committee, and a written informed consent was obtained from all patients. 
Statistical analysis

Results
General characteristics
The baseline clinical, echocardiographic and haemodynamic measures of the enrolled 269 patients are summarized in 
Angiographic findings
The LMCA-Co > _ 50% was documented in 22 (8.2%) out of the 269 patients who underwent CA, and % diameter stenosis were between 70% and 90% in 14 (64%) of these patients. The LMCA-Co was diagnosed during evaluation of PAA by MDCT prior to CA in 8 patients ( Figure 1A and B). The LMCA take-off angle in reference to left sinus of Valsalva was less than 30 in all patients with LMCA-Co whereas this angle was higher than 60 in other patients without LMCA-Co.
However, any narrowing in the distal LMCA segment or other segments of left and right coronary arteries was not documented. Because external compression by PAA resulted in an ovoid-shaped deformation of LMCA concomitant with narrowing of the take-off angle in reference to left sinus of Valsalva, the best plane transsecting the short axis of compressed LMCA was left anterior oblique (60 ) or anterior views with or without cranial angulations (30 ) while other planes transsecting the long-axis of compressed LMCA were found to miss the narrowings (Figure 2A-D) . Hoarseness due to recurrent nerve compression by PAA and typical angina were noted in all patients with LMCA-Co. Figure 3 ). For LMCA-Co, diagnosis of APAH-CHD due to PDA had a Sens of 36% and a Spec of 97%, PA diameter >40.5 mm had a Sens of 82% and a Spec of 82%, PA/Aortic diameter ratio >1.24 had a Sens of 91% and a Spec of 74%, PA mean pressure >49.5 mm Hg had a Sens of 93% and a Spec of 65%, and age of younger than 43.4 years had a Sens of 14% and a Spec of 80%.
Correlates of extrinsic LMCA compression
Management of LMCA compression
In patients with LMCA-Co >70% as assessed by diameter stenosis, bare-metal stents were implanted in 12 symptomatic patients (54.5%) without complication ( Figure 4A-C) . The median diameter and length of bare-metal stents were 4.2 mm (3.5-5.0), and 12.5 mm, 9-20 respectively. One patient underwent reconstructive PA surgery and ASD repair because of mild PAH and a low PVR. Another patient declined the LMCA stenting procedure.
In-hospital and post-discharge clinical course
A non-sudden cardiac death was observed on 10th day of LMCA stenting in one patient with severely compromised cardiac haemodynamics prior to stenting which remains unresponsive to subsequent treatments. During regular post-discharge follow-up period of median 17.3 months no death was documented.
Discussion
In this single-centre study based on large series of patients with PH, LMCA-Co > _ 50% was documented in 8.2% patients who underwent CA, and % diameter stenosis ranged between 70% and 90% in the majority of these patients. Hoarseness due to recurrent nerve compression and angina were noted in all patients with LMCA-Co. A younger age, a D-shaped septum, a higher PA systolic, mean and diastolic, pressures and PVR, a larger PA diameter with a smaller aortic diameter and clinical diagnosis of APAH-CHD due to PDA, ASD or VSD were significantly associated with LMCA-Co. The APAH due to PDA was the most powerful risk factor of LMCA-Co followed by a younger age, an increasing PA mean pressure, PA diameter, and PVR as the correlates of LMCA-Co. Bare-metal stents were implanted in 54.5% of these patients, and one patient underwent reconstructive PA surgery with ASD repair. Proximal LMCA-Co by a PAA was first described as a complication of severe PH 60 years ago. 3 Moreover, other situations resulting in PAA have also been documented to cause LMCA-Co. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] The majority of the data concerning LMCA stenting in this setting have been based on case reports or small series. 7, 8, [13] [14] [15] [16] [17] Cardiac MDCT provides a comprehensive method to evaluate the severity of extrinsic LMCA-Co, the angulation of this vessel relative to the left sinus of Valsalva, the underlying pathology of PAA, and left and right ventricular functions. 7, 9, [13] [14] [15] [16] [17] The degree of compression, a LMCA angle of take-off from the left sinus of Valsalva of <30% and a main PA/aorta diameter ratio >2.0 have been reported to increase the risk for LMCA-Co. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] In the ever largest series of Galie et al. 16 in which LMCA deformation patterns and management strategies were evaluated, 121 out of the 765 (15.8%) patients with PAH underwent MDCT because of their angina or angina-like symptoms. Four MDCT patterns described were as follows; (i) LMCA-Co, (ii) LMCA dislocation (a take-off angle <60 without compression), (iii) close proximity (PA to LMCA distance <1 mm, and (iv) normal pattern (PA to LMCA distance >1 mm). The MDCT evaluation showed LMCA-Co, LMCA dislocation and close proximity patterns in 28.9%, 40.5% and 8.3% of the patients, respectively. 16 Patients with first three patterns underwent selective CA, and LMCA-Co > _ 50% was diagnosed in 39, 7% of those with angina or angina-like chest pain. In other words, LMCACo was documented in 6% of the overall PH patients. Main PA diameter >40 mm as assessed by MDCT was found to predict LMCACo > _ 50%, and angiographic LMCA-Co > _ 50% was diagnosed in 10%, 30, 6%, and 91, 4% of the proximity, dislocation and compression patterns of MDCT, respectively. 16 The LMCA-Co > _ 50% was noted in 8.2% of our patients who underwent CA, and 4.4% of overall PH patients. The LMCA-Co has been reported to be associated with PA diameter and PA diameter/aortic diameter ratio, but not with the severity of PAH in two large PAH series. 13, 16 In contrast to these series, we found that not only PA diameter and PA diameter/aortic diameter ratio, but also clinical etiology of PDA, a younger age, and severity of PAH as defined by higher PA mean pressure and PVR predicted the risk of LMCA-Co. We also found that LMCA take-off angle in reference to left sinus of Valsalva was lower than 30 in all patients with LMCA-Co. However, neither the optimal treatment of PAA, nor management of LMCA-Co have been standardized. Because of the risk of PAA dissection and rupture, an aggressive surgical approach has been advocated for patients with PH. [18] [19] [20] [21] [22] [23] [24] [27] [28] [29] [30] Although there is no evidencebased consensus for surgery, adults with main PAA diameter >5.5 cm, > _5 mm increase in the diameter of the PAA in 6 months, clinical symptoms, co-existing severe valvular pathologies or shunt flow, and verification of extrinsic compression of LMCA or adjacent structures, thrombus formation in the PAA are considered as indications for surgery. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] On the other hand, patients with PH may have a high surgical risk and may need a heart-lung transplantation.
18-28
The LMCA stenting with encouraging angiographic results and satisfactory short-term clinical outcomes has been developed as the revascularization strategy of choice, and compression of the ostial or proximal part of this artery, sparing the LMCA bifurcation permits a single stent placement. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] In the large series of Galie et al. 16 85.4% of patients with LMCA stenosis >50% underwent LMCA stenting whereas both the rate of LMCA-Co and the LMCA stenting were lower in our study group. Moreover, in contrast to 48.9% rate of drug eluting stent placement in the series of Galie et al., 16 only bare metal stents were used for LMCA-Co treatment in our study. Because of the large diameters of LMCA, benefit of drug eluting stents in this setting has remained unproven whereas durability of radial force against extrinsic compression is a major challenge. 16, 17 Long-term follow-up data of these patients after LMCA stenting suggest a favourable clinical outcome despite the presence of a trend for statistically significant re-narrowing of the LMCA after stenting. 16 This implies the ongoing risk for progressive compression of LMCA by enlarged and overloaded PAs. 16, 17 Galie et al. 16 reported that the rates for death or double-lung transplant and rates for death, double- surgical plasty for LMCA-Co were 5% and 30% at 3 years, respectively. Except one in-hospital death seeming to be associated with underlying heart failure, we documented no death during follow-up of period. The selection of best methods for adjunctive periprocedural imaging and physiologic assessment in this patients is another concern. 17,31 Intravascular ultrasound with or without pressure wire can also be used as a guidance method to evaluate the LMCA-Co and to assess optimal stent sizing, deployment and apposition during stenting. 31 Because of the ostial location of the LMCA segment to be stented, the risk of stent displacement to the aorta is another critical issue. 32 Moreover, long-term antiplatelet management after LMCA stenting is another controversy in these patients.
Limitations
The absence of the detailed MDCT morphologic definition which may be predictive for LMCA-Co patterns, and quantitative assessment of flow obliteration in the presence of ovoid-shaped lumen with currently available methods such as intravascular ultrasound or fractional flow reserve in the decision making for management strategy may be considered as important limitations. The durability of the radial force of bare metal stents against progressive extrinsic compression due to increasing PA pressures is another concern. The long-term prospective randomized studies seem to be needed to evaluate whether LMCA stenting provides any additive benefit beyond the targeted PH treatments in this setting. Moreover, because of the too small size of the subgroup of patients with significant LMCA-Co, the multiple linear regression analysis that could be very important to evaluate the independent roles of different determinants on the genesis this complication was not possible. Accordingly, this issue remains as an important limitation of this study, and description of the findings should be less absolute since ROC analysis per se cannot be conclusive.
Conclusions
We demonstrate that LMCA-Co is the one of the most important complications of severe PAH, and alertness for this risk seems to be necessary in younger patients and in specific circumstances related with PAA including PDA and haemodynamically severe pulmonary vascular diseases. However, long-term benefit from LMCA stenting in this setting remains as a controversy.
